An FDA advisory committee has voted to lift restrictions on the manufacture of four peptides for human use, a move widely expected due to the influence of Health Secretary Robert F. Kennedy Jr. This decision proceeds despite ongoing concerns regarding the lack of robust evidence concerning the safety and effectiveness of these substances. The vote marks a significant shift in regulatory stance driven by political appointment rather than purely scientific consensus.
Background
Robert F. Kennedy Jr., as Secretary of Health and Human Services, has been actively reshaping federal health agencies and appointing allies to key advisory roles. This context suggests a broader trend of political influence over scientific regulatory processes within the US government.
- Source
- Ars Technica
- Published
- Jul 25, 2026 at 03:10 AM
- Score
- 7.0 / 10